Monopar Therapeutics — Form D
Monopar Therapeutics of NORTHBROOK, IL, a company, filed a Form D exempt-offering notice with the SEC on 2015-06-18. The offering totals $6.0M, of which $2.1M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2015-06-18
- Form: D
- Accession: 0001645469-15-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $6.0M
- Amount sold: $2.1M
- Remaining: $3.9M
- Minimum investment: $250K
- Investors: 8
- Date of first sale: 2015-06-10
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-242087
Issuer
- Name: Monopar Therapeutics
- CIK: 0001645469
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2015
- Address: 5 REVERE DRIVE, SUITE 200, NORTHBROOK, IL, 60062
- Phone: 6143958936
Officers, directors & promoters (9)
| Name | Role | Location |
|---|
| Chandler D Robinson | Promoter | Northbrook, IL |
| Michael J Brown | Director | Leawood, KS |
| Chandler D Robinson | Director | Northbrook, IL |
| Chandler D Robinson | Executive Officer | Northbrook, IL |
| Andrew P Mazar | Director | Northbrook, IL |
| Andrew P Mazar | Executive Officer | Northbrook, IL |
| Christopher M Starr | Director | Northbrook, IL |
| Christopher M Starr | Executive Officer | Northbrook, IL |
| Raymond W Anderson | Director | Northbrook, IL |
Other filings by this issuer (3)
More